Additionally, the prooxidant and antioxidant levels can be retained by TM8 and TM1. Our findings show that TM8 and TM1 are selective inhibitors of MAO-B and have potential therapeutic value for the treatment of neurological disorders. This evidence concerns the gene MAOB and nervous system disorder.